搜索筛选:
搜索耗时4.8205秒,为你在为你在102,285,761篇论文里面共找到 12 篇相符的论文内容
类      型:
[会议论文] 作者:Rongrong Luo,Caixia Liang,Jiarui Yao,Di Wu,Zhishang Zhang,Yuankai Shi,Xiaohong Han, 来源:2019中国肿瘤学大会 年份:2019
Objective Non-small cell lung cancer(NSCLC)accounts for 85%of lung cancer,the leading cause of cancer dearth worldwide.Autoantibodies(AAbs)have been recently recognized as auxiliary diagnostic biomark...
[期刊论文] 作者:Lin Gui,Xiaohong Han,Xiaohui He,Yuanyuan Song,Jiarui Yao,Jianliang Yang,Peng Liu, 来源:中国癌症研究(英文版) 年份:2016
[会议论文] 作者:Li Ma,Chunling Zhang,Jiarui Yao,Yuankai Shi,Hongying Yang,Fang Wang,Jia Li,Xiaohong Han, 来源:第六届中国肿瘤内科大会 年份:2012
[会议论文] 作者:Li Ma,Hongying Yang,Jia Li,Fang Wang,Chunling Zhang,Jiarui Yao,Xiaohong Han,Yuankai Shi, 来源:第六届中国肿瘤内科大会 年份:2012
Background: The measurement of the human epidermal growth factor receptor 2 (HER2) protein in the serum of metastatic breast cancer patients has now been reported, but there are no consistent data to...
[会议论文] 作者:Lei Zhang,Rongrong Luo,Lin Wang,Jiarui Yao,Di Wu,Zhishang Zhang,Xiaohong Han,Yuankai Shi, 来源:2019中国肿瘤学大会 年份:2019
Objective Metabolites and somatic mutations involved in the EGFR-TKI efficacy remains unclear in the first-line non-small cell lung cancer(NSCLC)patients with EGFR sensitizing mutation.Here we perform...
[期刊论文] 作者:Yan Qin,Xiaohong Han,Lin Wang,Ping Du,Jiarui Yao,Di Wu,Yuanyuan Song,Shuxiang Zhang,Le Tang,Yuankai Shi, 来源:Chinese Journal of Cancer Research 年份:2017
Objective: The recommended dose of prophylactic pegylated recombinant human granulocyte-colony stimulating factor(PEG rhG-CSF) is 100 μg/kg once per cycle for...
[期刊论文] 作者:Yan Qin,Xiaohong Han,Lin Wang,Ping Du,Jiarui Yao,Di Wu,Yuanyuan Song,Shuxiang Zhang,Le Tang,Yuankai Shi, 来源:中国癌症研究(英文版) 年份:2017
Objective:The recommended dose of prophylactic pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) is 100 μg/kg once per cycle for...
[会议论文] 作者:Xiaohong Han,Li Ma,Lingdi Zhao,Xiaohui He,Peng Liu,Shengyu Zhou,Jianliang Yang,Yan Qin,Sheng Yang,Jiarui Yao, 来源:第五届中国肿瘤内科大会 年份:2011
Purpose: Factors affecting progenitor cell mobilization in patients with non-Hodgkins lymphoma (NHL) and Hodgkins lymphoma (HL) are incompletely understood.The aim of this retrospective study was to d...
[会议论文] 作者:Junniao Liu,Ming Yang,Xiaoping Miao,Wen Tan,Tong Sun,Dan Zhao,Dongxin Lin,Xuemei Zhang,Yuankai Shi,Jiarui Yao, 来源:第一届国家癌症中心学术年会 年份:2011
[会议论文] 作者:Yongli Guo,Dianke Yu,Junniao Liu,Dongxin Lin,Xuemei Zhang,Ming Yang,Xiaoping Miao,Yuankai Shi,Jiarui Yao, 来源:第一届国家癌症中心学术年会 年份:2011
[期刊论文] 作者:Lin Gui,Xiaohong Han,Xiaohui He,Yuanyuan Song,Jiarui Yao,Jianliang Yang,Peng Liu,Yan Qin,Shuxiang Zhang, 来源:Chinese Journal of Cancer Research 年份:2016
Objective: This study was designed to determine the safety, pharmacokinetics and biologic effects of a humanmouse chimeric anti-CD20 monoclonal antibody(SCT400)...
[期刊论文] 作者:Xiaohui He,Shengyu Zhou,Peng Liu,Jianliang Yang,Changgong Zhang,Lin Gui,Yan Qin,Sheng Yang,Liya Zhao,Jiarui Yao, 来源:Chinese Journal of Cancer 年份:2015
Background: The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisolone(CHOP) is an eicient treatment of non-Hodgkin’s lymphoma(NHL). This stud...
相关搜索: